Drug use evaluation of vancomycin at medical ward of Yekatit 12, hospital medical college, Addis Ababa, Ethiopia, 2018
Keywords:Vancomycin, Drug use evaluation, Antibiotics, Empiric therapy, Ethiopia
Background: Drug use evaluation is an ongoing systematic process designed to maintain the appropriate medication during & after dispensing in order to assure appropriate therapeutic decision making and positive patient outcome.
Methods: An institutional based cross-sectional study design was conducted to analyze drug use of vancomycin by using medication charts and medical note of patients that were admitted in the medical ward of Yekatit 12 Hospital Medical College. Data was analyzed using SPSS version 20. Patients who were admitted from medical ward and whose age were ≥18 years were eligible provided that they take Vancomycin during the study period were included and Patients with medical records of insufficient or illegible information’s were excluded. Structured check list was used for data collection, and the sample size was 169. Convenience sampling technique was used.
Results: Among 169 patients 136 (80.5%) had empiric treatments, the remaining 33 (19.5%) had specific treatments. Among 169 patients 61 (36.1%) had Infection during his/her stay in hospital of which 47 (77%) were hospital acquired pneumonia, 169 patients 39 (23.08%) had Vancomycin indication for hospital acquired pneumonia followed by 21 (12.4%), 21 (12.4%), meningitis and PCP respectively. The finding indicated that only 135 (79.9%) were appropriate regarding frequency, 124 (73.4%) were appropriate regarding dose, 104 (61.6%) were appropriate regarding duration, and the appropriate indication were only 128 (75.7%).
Conclusions: Vancomycine was mostly indicated as empiric therapy and only 135 (79.9%) were appropriately prescribed with respect to frequency, 128 (75.7%) were appropriate regarding indication and 124 (73.4%) were appropriate regarding to dose, 104 (61.6%) were appropriate regarding to duration. All physicians should prescribe drugs according to the guidelines.
Maciej C, Asok K. Vancomycin-resistant Enterococcus. Ann Acad Med Singapore. 2013;37:861-9.
Moacyr S, Luci C, Alexandre R. Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study. BMC Infect Dis. 2014;7(88):1-6.
Center of disease control and prevention guideline for antibiotic resistance threats in the United States 2013. Available at: https://www.cdc.gov/ drugresi-stance/pdf/ar-threats-2013-508.pdf. Accessed on 20 April 2020.
Centers of disease control and prevention for management of multidrug-resistant organisms in healthcare settings 20010. Available at: https://www.cdc.gov/infectioncontrol/pdf/guidelines/mdro-guidelines.pdf. Accessed on 20 April 2020.
Centers for disease control and prevention/healthcare infection control practices advisory committee (hicpac). draft guidelines for environmental infection control in healthcare facilities in Atlanta 2012. Available at: https://www.cdc.gov/hicpac/pdf/ archive/2013-march-hicpac-meeting.pdf. Accessed on 20 April 2020.
Kevin G, Gerald S, David W. Vancomycin prescribing practices in hospitalized chronic hemodialysis patients. Am J Kidney Dis. 2013;35:64-8.
Daniela O, Marli S, Renato S. Vancomycin use in a hospital with high prevalence of methicillin-resistant staphylococcus aureus: comparison with hospital infection control practices advisory committee guidelines. BJID. 2011;11(1):53-6.
Drug administration and control authority of Ethiopia in collaboration with management sciences for health, strengthening pharmaceutical systems (MSH/SPS) August 2009. Available at: http://www.fmhaca.gov.et/publications-library/. Accessed on 20 April 2020.
Antimicrobial prophylaxis for surgery. Treat guide Med Lett. Available at: https://secure.medicalletter. org/article-share?a=1495a&p=tml&title= Antimicrobial%20Prophylaxis%20for%20Surgery&cannotaccesstitle=1. Accessed on 20 April 2020.
Navarro R. Drug Utilization Review Strategies. Managed Care Pharmacy Practice. 2010;8:215-29.
Arora S, Devi P, Arora U, Devi B. Prevalence of methicillin resistant staphylococcus aureus(MRSA) in a tertiary care hospital in northern India. J Lab physicians. 2010;5:125-232.
Azhar B. Economical access to antibiotics in an era of increasing resistance: a study from Lahore, Pakistan; Uppsala university; VT 2010; Accesss date-April 17,2018, http://www.reactgroup.org/uploads/publications/react-publications/Economical%20access%20to%20antibiotics%20-%20Bina%20Ahzar.pdf
Wasam L, Mehreen F, Fatima A, Khawaja T. Drug utilization evaluation of vancomycin in teaching hospitals of Lahore. J Pharm Sci Res. 2017;4(2): 1728-33.
Jyothi K, JagadishBabu D. Drug utilization evaluation of cephalosporins in general medicine units of rural tertiary care hospital. Int J Curr Pharm Res. 2012;4(2):88-91.
Guidelines on Medication-use evaluation. Available at https://www.ashp.org/-/media/assets/policy-guidelines/docs/guidelines/medication-use-evaluation.ashx. Accessed on 20 April 2020.
Zeleke B, Engidawork E. Drug utilization evaluation of vancomycin. American Journal of Health Research. 2015;3(6): 333-7.
Joyce H, Donald J, Benjamin S. Vancomycin utilization at a teaching hospital in Hong Kong. Am J Health-Syst Pharm. 2018;58:2167-9.
Afsaneh V, Aziz J, Sakineh S. Vancomycin utilization evaluation at hematology-oncology ward of a teaching hospital in Iran. Iranian J Pharm Res. 2012;11(1):163-70.
Hamishehkar H, Ebrahimi D, Mahmoodpoor A, Mashayekhi S, Asgharian P, Reazee H. Drug utilization evaluation of vancomycin in a teaching hospital in Tabriz-Iran. Pharma Sci. 2015;21:25-9.
El-Ashmony SMA. Different patterns of inappropriate antimicrobial use: a cross sectional study. Life Sci J. 2013;10:216-22.
Lodise TP, Lomaestro B, and Graves J, Drusano GL. Larger Vancomycin Doses (≥4 grams/day) are Associated with an Increased Incidence of Nephrotoxicity. Antimicrob Agents Chemother. 2010;52(4):1330-6.
Navarro R. Drug Utilization Review Strategies. Managed Care Pharmacy Practice. 2008;8:215-29.
Tagwa A. M. Salih et al; Drug Utilization Evaluation of Vancomycin among Patients in Jafar Ibn Auf Pediatric Hospital, 2018; 8:1708.
Fahimi F, Soleymani F, Tavakoli-Ardakani M. Vancomycin utilization evaluation in a teaching hospital: A case- series study in Iran. J Pharm Care. 2013;1:13-6.
Drug administration and control authority of ethiopia in collaboration with management sciences for health, strengthening pharmaceutical systems (MSH/SPS) August 2013. Available at: http://www.fmhaca.gov.et/publications-library/. Accessed on 20 April 2020.
Ayazkhoo L, Mousavi S, Ramazani F, Ayatollahi-Tafti M, Sa’dabadi Z, Sistanizad M. Vancomycin utilization evaluation: are we dosing appropriately? J Pharm Care. 2013;1(4):149-52.
Dehghan F, Khorami N, Taleghani V. Drug utilization evaluation of vancomycin in pediatric department. Novelty in Biomedicine (NBM). 2018;1(9):9-14.